[1]陈甘潇 张中和 胡丹 夏豪.发热诱发Brugada综合征的临床及心电图特征[J].心血管病学进展,2021,(1):81-85.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
　CHEN Ganxiao,ZHANG Zhonghe,HU Dan,et al.Clinical and Electrocardiogram Characteristics of Fever-induced Brugada Syndrome[J].Advances in Cardiovascular Diseases,2021,(1):81-85.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
点击复制

发热诱发Brugada综合征的临床及心电图特征()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2021年1期
页码:
81-85
栏目:
论著
出版日期:
2021-01-25

文章信息/Info

Title:
Clinical and Electrocardiogram Characteristics of Fever-induced Brugada Syndrome
文章编号:
202005151
作者:
陈甘潇 张中和 胡丹 夏豪
(武汉大学人民医院心血管内科,湖北 武汉 430000 )
Author(s):
CHEN Ganxiao;  ZHANG Zhonghe;  HU Dan;  XIA Hao
(Department of Cardiology, Renmin Hospital of Wuhan University,Wuhan 430000,Hubei,China)
关键词:
Brugada综合征; 发热; 药物激发试验; 恶性心律失常
Keywords:
Brugada syndrome; Fever; Drug challenge test; Malignant arrhythmia
DOI:
10.16806/j.cnki.issn.1004-3934.2021.01.000
摘要:
目的 探究发热诱发Brugada综合征的临床及心电图特点。 方法 选择 2000年1月—2019年1月武汉大学人民医院收治Brugada综合征患者112例，根据诱发因素将全部病例分为发热组（34例）和非发热组，比较分析两组临床特点及药物激发试验结果。结果 发热组在主要心血管事件发生率及家族史比例方面均显著大于非发热组（52.94% vs 29.49%, P=0.018；17.65% vs 3.85%, P=0.036）；药物激发试验阳性的发热组患者表现出较发热时更长的QT间期和PR间期[（371.00±43.06）ms vs （327.00±36.89）ms, P =0.015；（187.88±27.41）ms vs（156.75±9.5）ms, P=0.022]。结论 发热诱发Brugada综合征存在着相对较高的主要心血管事件风险和相关家族史比例，同一患者由发热与药物诱导的Brugada心电图也存在差异，表明发热诱发Brugada综合征具备相对独特的临床和心电图特点。
Abstract:
Objective To explore the clinical and electrocardiogram characteristics of fever-induced Brugada syndrome. Methods From January 2000 to January 2019, 112 patients with Brugada syndrome were treated in Renmin Hospital of Wuhan University, including 34 patients with fever-induced Brugada syndrome. The clinical characteristics and drug challenge test results were analyzed. According to the inducing factors,they were divided into fever-induced group and non-fever group. The clinical data of each group were compared to explore the fever-induced Brugada syndrome’s characteristics. Results The ratio of major cardiovascular events and related positive family history in patients with fever-induced Brugada syndrome were significantly higher than those in non-febrile patients(52.94% vs 29.49%,P=0.018;17.65% vs 3.85%,P=0.036). Patients in fever group who tested positive in drug challenge test,showed prolonged QT interval and PR interval than that during fever [(371.00±43.06)ms vs (327.00±36.89)ms, P=0.015;(187.88 ±27.41)ms vs (156.75±9.56)ms, P=0.022]. Conclusion Fever-induced Brugada syndrome has relatively high incidence of major cardiovascular events,and a relatively large proportion of positive family history. This study shows that fever-induced Brugada syndrome has relatively unique clinical characteristics

参考文献/References:

[1] Brugada P,Brugada J. Right bundle branch block,persistent ST segment elevation and sudden cardiac death:a distinct clinical and electrocardiographic syndrome. A multicenter report[J]. J Am Coll Cardiol,1992,20(6):1391-1396.

[2] Wilde AA,Antzelevitch C,Borggrefe M,et al. Proposed diagnostic criteria for the Brugada syndrome:consensus report[J]. Circulation,2002,106(19):2514-2519.

[3] Kamakura S,Ohe T,Nakazawa K,et al. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3[J]. Circ Arrhythm Electrophysiol,2009,2(5):495-503.

[4] Junttila MJ,Gonzalez M,Lizotte E,et al. Induced Brugada-type electrocardiogram,a sign for imminent malignant arrhythmias[J]. Circulation,2008,117(14):1890-1893.

[5] Rolf S,Bruns HJ,Wichter T,et al. The ajmaline challenge in Brugada syndrome:diagnostic impact, safety,and recommended protocol[J]. Eur Heart J,2003,24(12):1104-1112.

[6] Priori SG,Wilde AA,Horie M,et al. Executive summary:HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes[J]. Heart Rhythm,2013,10(12):e85-108.

[7] Gonzalez Rebollo JM,Hernandez Madrid A,Garcia A,et al. Recurrent ventricular fibrillation during a febrile illness in a patient with the Brugada syndrome[J]. Rev Esp Cardiol,2000,53(5):755-757.

[8] Mizusawa Y,Morita H,Adler A,et al. Prognostic significance of fever-induced Brugada syndrome[J]. Heart Rhythm,2016,13(7):1515-1520.

[9] Morita H,Nagase S,Kusano K,et al. Spontaneous T wave alternans and premature ventricular contractions during febrile illness in a patient with Brugada syndrome[J]. J Cardiovasc Electrophysiol,2002,13(8):816-818.

[10] Adler A,Topaz G,Heller K,et al. Fever-induced Brugada pattern:how common is it and what does it mean[J]. Heart Rhythm,2013,10(9):1375-1382.

[11] Rattanawong P,Vutthikraivit W,Charoensri A,et al. Fever-induced Brugada syndrome is more common than previously suspected:a cross-sectional study from an endemic area[J]. Ann Noninvasive Electrocardiol,2016,21(2):136-141.

[12] Michowitz Y,Milman A,Sarquella-Brugada G,et al. Fever-related arrhythmic events in the multicenter survey on arrhythmic events in Brugada syndrome[J]. Heart Rhythm,2018,15(9):1394-1401.

[13] Yamagata K,Horie M,Aiba T,et al. Genotype-phenotype correlation of SCN5A mutation for the clinical and electrocardiographic characteristics of probands with Brugada syndrome:a Japanese multicenter registry[J]. Circulation,2017,135(23):2255-2270.

[14] Miyazaki T,Mitamura H,Miyoshi S,et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome[J]. J Am Coll Cardiol,1996,27(5):1061-1070.

[15] Brugada R,Brugada J,Antzelevitch C,et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts[J]. Circulation,2000,101(5):510-515.

[16] Shimizu W,Antzelevitch C,Suyama K,et al. Effect of sodium channel blockers on ST segment, QRS duration,and corrected QT interval in patients with Brugada syndrome[J]. J Cardiovasc Electrophysiol,2000,11(12):1320-1329.

[17] Hong K,Brugada J,Oliva A,et al. Value of electrocardiographic parameters and ajmaline test in the diagnosis of Brugada syndrome caused by SCN5A mutations[J]. Circulation,2004,110(19):3023-3027.

[18] Hasdemir C,Payzin S,Kocabas U,et al. High prevalence of concealed Brugada syndrome in patients with atrioventricular nodal reentrant tachycardia[J]. Heart Rhythm,2015,12(7):1584-1594.

[19] Barra S,Provid ência R,Nascimento J. Fever outperforms flecainide test in the unmasking of type 1 Brugada syndrome electrocardiogram[J]. Europace,2013,15(3):394.

相似文献/References:

[1]胡康新,潘洁,姚文亮.Brugada综合征若干临床进展[J].心血管病学进展,2016,(1):94.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.025]
　HU Kangxin,PAN Jie,YAO Wenliang.Clinical Advances on Brugada Syndrome[J].Advances in Cardiovascular Diseases,2016,(1):94.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.025]
[2]简易 李耀东.Brugada综合征诊断、遗传学及风险分层的研究进展[J].心血管病学进展,2024,(6):519.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.010]
　JIAN Yi,LI Yaodong.Diagnosis,Genetics and Risk Stratification of Brugada Syndrome[J].Advances in Cardiovascular Diseases,2024,(1):519.[doi:10.16806/j.cnki.issn.1004-3934.2024.06.010]

更新日期/Last Update: 2021-03-18